Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes

Vivek P. Chavda; Mahesh T. Chhabria; Vasso Apostolopoulos

doi:10.3390/biologics2030013

Biologics (Jul 2022)

Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes

Vivek P. Chavda,
Mahesh T. Chhabria,
Vasso Apostolopoulos

Affiliations

Vivek P. Chavda: Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380009, Gujarat, India
Mahesh T. Chhabria: Department of Pharmaceutical Chemistry, L M College of Pharmacy, Ahmedabad 380009, Gujarat, India
Vasso Apostolopoulos: Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia

DOI: https://doi.org/10.3390/biologics2030013
Journal volume & issue: Vol. 2, no. 3
pp. 165 – 170

Abstract

Read online

Patients with an immunocompromised state are at risk of developing a long-term infection from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2) [...]

n/a

Published in Biologics

ISSN: 2673-8449 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Biology (General)
Website: https://www.mdpi.com/journal/biologics

About the journal

Abstract

Keywords